A detailed history of Main Street Research LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Main Street Research LLC holds 462,068 shares of NVO stock, worth $47 Million. This represents 3.53% of its overall portfolio holdings.

Number of Shares
462,068
Previous 461,087 0.21%
Holding current value
$47 Million
Previous $65.8 Million 16.41%
% of portfolio
3.53%
Previous 4.43%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$119.07 - $145.42 $116,807 - $142,657
981 Added 0.21%
462,068 $55 Million
Q2 2024

Jul 29, 2024

SELL
$122.71 - $146.91 $150,319 - $179,964
-1,225 Reduced 0.26%
461,087 $65.8 Million
Q1 2024

May 01, 2024

SELL
$102.11 - $135.92 $462,966 - $616,261
-4,534 Reduced 0.97%
462,312 $59.4 Million
Q4 2023

Jan 30, 2024

SELL
$87.78 - $105.45 $747,534 - $898,012
-8,516 Reduced 1.79%
466,846 $48.3 Million
Q3 2023

Nov 03, 2023

BUY
$90.94 - $199.54 $21.2 Million - $46.5 Million
233,228 Added 96.32%
475,362 $43.2 Million
Q2 2023

Aug 08, 2023

BUY
$155.98 - $172.65 $471,527 - $521,920
3,023 Added 1.26%
242,134 $39.2 Million
Q1 2023

May 01, 2023

SELL
$132.34 - $159.14 $290,353 - $349,153
-2,194 Reduced 0.91%
239,111 $38.1 Million
Q4 2022

Feb 06, 2023

BUY
$102.55 - $135.33 $244,786 - $323,032
2,387 Added 1.0%
241,305 $32.7 Million
Q3 2022

Nov 10, 2022

BUY
$95.28 - $116.93 $457,344 - $561,264
4,800 Added 2.05%
238,918 $23.8 Million
Q2 2022

Aug 12, 2022

BUY
$103.24 - $121.81 $108,195 - $127,656
1,048 Added 0.45%
234,118 $26.1 Million
Q1 2022

May 05, 2022

BUY
$93.1 - $112.54 $21.7 Million - $26.2 Million
233,070 New
233,070 $25.9 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $230B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Main Street Research LLC Portfolio

Follow Main Street Research LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Main Street Research LLC, based on Form 13F filings with the SEC.

News

Stay updated on Main Street Research LLC with notifications on news.